Biogen, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4439
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or ‘the company’) formerly known as Biogen Idec, is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of hematology, neurology and immunology. The company’s key products include Tecfidera, Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. Biogen is headquartered in Weston, Massachusetts, the US.

Scope

- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Biogen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Biogen, Inc.: Company Overview 9
Biogen, Inc.: Overview and Key Facts 9
Biogen, Inc.: Overview 9
Biogen, Inc.: Key Facts 9
Biogen, Inc.: Key Employees 11
Biogen, Inc.: Key Employee Biographies 13
Biogen, Inc.: Major Products and Services 19
Biogen, Inc.: Company History 21
Biogen, Inc.: Management Statement 27
Biogen, Inc.: Locations and Subsidiaries 32
Biogen, Inc.: Key Competitors 33
Biogen, Inc.: Company Analysis 34
Biogen, Inc.: Business Description 34
Biogen, Inc.: SWOT Analysis 36
Biogen, Inc.: SWOT Overview 36
Biogen, Inc.: Strengths 36
Biogen, Inc.: Weaknesses 37
Biogen, Inc.: Opportunities 37
Biogen, Inc.: Threats 39
Biogen, Inc.: Corporate Financial Deals Activity 40
Biogen, Inc.: Financial Deals Overview 40
Biogen, Inc.: Targets and Partners 42
Biogen, Inc.: Top Deals 2014 – 2018YTD* 44
Biogen, Inc.: Advisors 45
Biogen, Inc.: Top Financial Advisors 45
Biogen, Inc.: Mergers and Acquisitions 46
Biogen, Inc.: Corporate Venturing 47
Biogen, Inc.: Partnership 48
Biogen, Inc.: Divestments 49
Biogen, Inc.: Recent Developments 50
Biogen, Inc.: News and Events Summary 50
Biogen, Inc.: Business Expansion 54
Biogen, Inc.: Contracts 54
Biogen, Inc.: Financial Deals 55
Biogen, Inc.: Financial Performance 55
Biogen, Inc.: Grants 56
Biogen, Inc.: Market Developments 56
Biogen, Inc.: Strategy and Operations 57
Appendix 58
Contact Us 58
Methodology 58
About MarketLine 59

List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Locations and Subsidiaries
Table 4: Biogen, Inc.: Key Competitors
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Biogen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Biogen, Inc.: Targets and Partners
Table 10: Biogen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Biogen, Inc.: News and Events Summary
Table 20: Biogen, Inc.: Business Expansion
Table 21: Biogen, Inc.: Contracts
Table 22: Biogen, Inc.: Financial Deals
Table 23: Biogen, Inc.: Financial Performance
Table 24: Biogen, Inc.: Grants
Table 25: Biogen, Inc.: Market Developments
Table 26: Biogen, Inc.: Strategy and Operations

List of Figures
Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Biogen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Biogen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Biogen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Biogen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Biogen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Biogen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Biogen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Biogen, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trivitron Healthcare Pvt Ltd:企業のM&A・事業提携・投資動向
    Trivitron Healthcare Pvt Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Trivitron Healthcare Pvt Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Georox Resources Inc (GXR):石油・ガス:M&Aディール及び事業提携情報
    Summary Georox Resources Inc (Georox Resources), formerly Oromonte Resources Inc is an oil and gas company that acquires, develops and explores petroleum and natural gas properties in Western Canada. The company's projects include Silverdale property, GP Channel project, Sparky Non Channel project, …
  • Purdue Pharma L.P.:企業の戦略・SWOT・財務情報
    Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report Summary Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cardiva Medical Inc:企業の戦略的SWOT分析
    Cardiva Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Western Digital Corp (WDC):企業の財務・戦略的SWOT分析
    Western Digital Corp (WDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Zhejiang Jianfeng Group Company Ltd (600668):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jianfeng Group Company Ltd (Jianfeng) is a diversified company. The company operates in the business of manufacturing cement, pharmaceuticals, health products, telecommunication and cables. It offers cement products that includes composite, ordinary, and slag Portland cement product …
  • BOE Technology Group Co Ltd:戦略・SWOT・企業財務分析
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Taiwan Semiconductor Manufacturing Company Limited:企業のM&A・事業提携・投資動向
    Taiwan Semiconductor Manufacturing Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taiwan Semiconductor Manufacturing Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business de …
  • Nidek Co Ltd:製品パイプライン分析
    Summary Nidek Co Ltd (Nidek) is a medical device company that designs, manufactures, distributes and leases ophthalmic and diagnostic equipment. Its products category encompasses ophthalmology and optometry software for advanced angioscan; lens edging technology for manufacturing eyeglasses, and sem …
  • G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • Sumitomo Rubber Industries Ltd (5110):企業の財務・戦略的SWOT分析
    Sumitomo Rubber Industries Ltd (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Titan Petrochemicals Group Ltd (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Isarna Therapeutics GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that develops products for ophthalmic, fibrotic diseases and cancers. The company offers antisense technology based drugs that treats aggressive tumor diseases. Its product include TGF-ß, a in …
  • Legacy Reserves LP (LGCY):石油・ガス:M&Aディール及び事業提携情報
    Summary Legacy Reserves LP (Legacy Reserves) is an oil and gas exploration and production company that acquires and develops oil and natural gas properties in the Permian Basin, Mid-Continent and Rocky Mountain regions of the US. The company provides Permian Basin which is an oil and natural gas pro …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆